AzTrials
AzTrials

Free Gingival GraftNCT05779800

The Use of Flowable Resin Composite Stent in Reduction of Donor Site Morbidity After Free Gingival Graft Harvesting

A study testing Flowble resin composite stent and periodontal pack in people with Free Gingival Graft, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

After harvesting free gingival graft from the hard palate, Postoperative pain as well as bleeding are the most common complications.Different agents were used to protect the denuded areas on the palate as gelatin sponge, Hyaluronic acid gel and platelet rich fibrin (PRF) but still no gold standard material is present. Read more about this study

Who is it for?
Ages 21 to 62 yearsHealthy volunteers can take part
Conditions the study is for
Free Gingival Graft
What is being tested?
Flowble resin composite stent and periodontal pack
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteEgypt
Study dates
15 Feb 2023to 5 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 62 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with mucogingival defects scheduled for free gingival graft or de-epithelialized connective tissue graft.
  • Systemically healthy

Who cannot join

  • Smokers
  • Occlusal trauma at site of graft
  • Pregnancy and lactation
  • Patients allergic to the used agents
  • Severe gagging reflex

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Faculty of dentistry, Cairo univesity

    Cairo, Manial, 11

    Ahmed M Barbari, A.Professor, 00201223153678, ahmed.barbari@dentistry.cu.edu.eg

    Faculty of dentistry, Cairo univesity, 0020223642705, dentmail@dentistry.cu.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Clinical Comparison of the Use of Flowable Resin Composite Stent Versus Periodontal Pack to Reduce Donor Site Morbidity After Free Gingival Graft Harvesting: A Randomized Clinical Trial

After harvesting free gingival graft from the hard palate, Postoperative pain as well as bleeding are the most common complications.Different agents were used to protect the denuded areas on the palate as gelatin sponge, Hyaluronic acid gel and platelet rich fibrin (PRF) but still no gold standard material is present.

PICO format:

Read more

P: patients with mucogingival problems in need for free gingival graft or de-epithelialized connective tissue graft.I: Flowable resin composite stent. C: Periodontal pack. O: Post-operative pain T: day 3, 7, 14, 21 and 42 postoperative.

Aim of the study:

To compare the effect of flowable composite stent versus periodontal pack applied to palatal donor site after free gingival graft harvesting in terms of post-operative pain reduction.

Read the detailed description

Intervention:

Flowable resin composite stent.

Procedure:

After the palatal sites be anaesthetized with 0.3 ml of a solution of 4% Articaine and 0.001% Adrenalin. Graft harvesting will be performed by basic surgical techniques described by Miller (1982). A rectangular shaped piece of mucosa will be harvested from the area of the hard palate by a split-thickness dissection.

The graft will then be used as it on the recipient bed. The graft dimensions will be recorded (width and length).

Denuded palatal area will then be protected using one of the following options:

  1. Periodontal pack (control group)
  2. flowble resin composite NEXOCOMP FLOW (intervention group)

Postoperative instructions:

Postoperative instructions will include discontinuing tooth brushing and flossing around the surgical sites until the day of periodontal dressing removal (day 7).

Patients will be directed to consume only soft foods during the first week and to avoid any mechanical trauma.

Patients will be scheduled to be seen on days 7, 14, 21 and 42 Periodontal pack and flowble resin composite stent will be first removed on day 7, and donor sites will be evaluated using selected parameters in both groups.

Thereafter, all patients will be followed up on days 14, 21 and 42 for further evaluation.

Being tested
Flowble resin composite stent, periodontal pack
Keywords
palatal donor site, Gingival Recession, Periodontal Diseases, Protective Agents, flowable composite
Medical subject headings
Gingival Recession, Periodontal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Flowble resin composite stentDevice

    Also called NEXOCOMP FLOW

    Flowble resin composite is a filling material used in operative dentistry and characterized by being flow and easily adapting the surfaces.

  • periodontal packDevice

    Also called COE-PAK

    Non eugenol containing dressing supplied in two tubes

Study groups in NCT05779800
Study groupRoleWhat they receive
Flowable resin composite stent groupExperimentalFlowable resin composite is a bio compatible material used in dental field many years ago.
Receives: Device: Flowble resin composite stent
Periodontal pack groupActive comparatorNon eugenol containing periodontal pack used in periodontal surgeries to protect the wound. Other name :COE_PAK
Receives: Device: periodontal pack

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post operative pain

    Pain score reported by the patient directly through Visual Analogue Scale score (between 0 and 100. 0: no pain, 10: minimal pain, 50:moderate pain, 100: severe pain)

    Measured: on day 7

Secondary outcomes (2)
  1. Color match

    The color of the palatal mucosa will be assessed by comparing it with that of the adjacent and opposite side by using the objective VAS (VAS score 0-10) represented by a continuous line, by a clinician blinded to the treatment group assignment.

    Measured: On day 42

  2. wound size

    To be recorded using (UNC 15) periodontal probe to the nearest measurement of 0.5 mm , length and width only

    Measured: at day 21

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2023
  2. Study start15 Feb 2023
  3. Primary completion8 Nov 2023 (estimated)
  4. Study completion5 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05779800
Sponsor's protocol ID
9322
Status last verified
Mar 2023
First submitted
25 Feb 2023
Last updated
22 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Flowble resin composite stent and periodontal pack in people with Free Gingival Graft, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed E Temraz, bachelor (00201020117827, mohamed.temraz@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post operative pain (time frame: on day 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in